HEMISPHERE ENERGY CORP (HME.CA) Fundamental Analysis & Valuation
TSX-V:HME • CA4236301020
Current stock price
2.98 CAD
+0.01 (+0.34%)
Last:
This HME.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HME.CA Profitability Analysis
1.1 Basic Checks
- In the past year HME was profitable.
- In the past year HME had a positive cash flow from operations.
- HME had positive earnings in each of the past 5 years.
- HME had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- HME has a Return On Assets of 23.12%. This is amongst the best in the industry. HME outperforms 98.03% of its industry peers.
- HME has a Return On Equity of 34.75%. This is amongst the best in the industry. HME outperforms 98.52% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 29.46%, HME belongs to the top of the industry, outperforming 99.01% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for HME is significantly above the industry average of 6.97%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 23.12% | ||
| ROE | 34.75% | ||
| ROIC | 29.46% |
ROA(3y)26.51%
ROA(5y)23.13%
ROE(3y)39.59%
ROE(5y)36.39%
ROIC(3y)32.46%
ROIC(5y)33.96%
1.3 Margins
- The Profit Margin of HME (29.84%) is better than 94.58% of its industry peers.
- HME's Profit Margin has improved in the last couple of years.
- HME has a Operating Margin of 42.20%. This is amongst the best in the industry. HME outperforms 92.61% of its industry peers.
- In the last couple of years the Operating Margin of HME has grown nicely.
- With a decent Gross Margin value of 60.69%, HME is doing good in the industry, outperforming 77.83% of the companies in the same industry.
- HME's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.2% | ||
| PM (TTM) | 29.84% | ||
| GM | 60.69% |
OM growth 3Y-2.15%
OM growth 5Y14.92%
PM growth 3Y10.62%
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y1.06%
2. HME.CA Health Analysis
2.1 Basic Checks
- HME has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for HME has been reduced compared to 1 year ago.
- The number of shares outstanding for HME has been increased compared to 5 years ago.
- Compared to 1 year ago, HME has an improved debt to assets ratio.
2.2 Solvency
- HME has an Altman-Z score of 6.34. This indicates that HME is financially healthy and has little risk of bankruptcy at the moment.
- HME's Altman-Z score of 6.34 is amongst the best of the industry. HME outperforms 85.71% of its industry peers.
- The Debt to FCF ratio of HME is 0.09, which is an excellent value as it means it would take HME, only 0.09 years of fcf income to pay off all of its debts.
- HME has a Debt to FCF ratio of 0.09. This is amongst the best in the industry. HME outperforms 96.55% of its industry peers.
- A Debt/Equity ratio of 0.03 indicates that HME is not too dependend on debt financing.
- With a decent Debt to Equity ratio value of 0.03, HME is doing good in the industry, outperforming 76.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.09 | ||
| Altman-Z | 6.34 |
ROIC/WACC3.67
WACC8.03%
2.3 Liquidity
- A Current Ratio of 1.37 indicates that HME should not have too much problems paying its short term obligations.
- The Current ratio of HME (1.37) is better than 69.46% of its industry peers.
- HME has a Quick Ratio of 1.37. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
- HME's Quick ratio of 1.37 is fine compared to the rest of the industry. HME outperforms 70.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 |
3. HME.CA Growth Analysis
3.1 Past
- The earnings per share for HME have decreased strongly by -15.15% in the last year.
- The Earnings Per Share has been growing by 10.83% on average over the past years. This is quite good.
- The Revenue has decreased by -6.07% in the past year.
- The Revenue has been growing by 38.14% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-15.15%
EPS 3Y10.83%
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)-6.07%
Revenue growth 3Y-0.99%
Revenue growth 5Y38.14%
Sales Q2Q%-18.71%
3.2 Future
- HME is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -16.11% yearly.
- The Revenue is expected to decrease by -7.33% on average over the next years.
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. HME.CA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 10.64, which indicates a very decent valuation of HME.
- Based on the Price/Earnings ratio, HME is valued a bit cheaper than 75.86% of the companies in the same industry.
- When comparing the Price/Earnings ratio of HME to the average of the S&P500 Index (26.64), we can say HME is valued rather cheaply.
- A Price/Forward Earnings ratio of 11.57 indicates a reasonable valuation of HME.
- HME's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HME is cheaper than 74.38% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 21.36, HME is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.64 | ||
| Fwd PE | 11.57 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HME indicates a rather cheap valuation: HME is cheaper than 90.64% of the companies listed in the same industry.
- HME's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HME is cheaper than 91.63% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.81 | ||
| EV/EBITDA | 5.17 |
4.3 Compensation for Growth
- HME has an outstanding profitability rating, which may justify a higher PE ratio.
- HME's earnings are expected to decrease with -16.11% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
5. HME.CA Dividend Analysis
5.1 Amount
- HME has a Yearly Dividend Yield of 3.37%. Purely for dividend investing, there may be better candidates out there.
- HME's Dividend Yield is a higher than the industry average which is at 3.11.
- Compared to an average S&P500 Dividend Yield of 1.80, HME pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.37% |
5.2 History
- HME has been paying a dividend for over 5 years, so it has already some track record.
- HME has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
- HME pays out 54.76% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP54.76%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
HME.CA Fundamentals: All Metrics, Ratios and Statistics
TSX-V:HME (5/1/2026, 7:00:00 PM)
2.98
+0.01 (+0.34%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Industry Strength86.61
Industry Growth44.78
Earnings (Last)04-15 2026-04-15/bmo
Earnings (Next)05-20 2026-05-20
Inst Owners0.94%
Inst Owner ChangeN/A
Ins Owners10.46%
Ins Owner ChangeN/A
Market Cap281.01M
Revenue(TTM)93.86M
Net Income(TTM)28.01M
Analysts84.44
Price Target2.96 (-0.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.37% |
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP54.76%
Div Incr Years0
Div Non Decr Years3
Ex-Date05-14 2026-05-14 (0.03)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11%
Min EPS beat(2)-19.09%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-5.53%
Min EPS beat(4)-19.09%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.2%
EPS beat(12)4
Avg EPS beat(12)-3.78%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.09%
Min Revenue beat(2)-3.98%
Max Revenue beat(2)-0.21%
Revenue beat(4)2
Avg Revenue beat(4)1.55%
Min Revenue beat(4)-3.98%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)1.46%
Revenue beat(12)7
Avg Revenue beat(12)0.74%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)19.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-9.09%
EPS NY rev (3m)-3.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.64 | ||
| Fwd PE | 11.57 | ||
| P/S | 2.99 | ||
| P/FCF | 8.81 | ||
| P/OCF | 5.83 | ||
| P/B | 3.49 | ||
| P/tB | 3.49 | ||
| EV/EBITDA | 5.17 |
EPS(TTM)0.28
EY9.4%
EPS(NY)0.26
Fwd EY8.64%
FCF(TTM)0.34
FCFY11.35%
OCF(TTM)0.51
OCFY17.14%
SpS1
BVpS0.85
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.32039 (-22.13%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 23.12% | ||
| ROE | 34.75% | ||
| ROCE | 39.28% | ||
| ROIC | 29.46% | ||
| ROICexc | 36.52% | ||
| ROICexgc | 36.52% | ||
| OM | 42.2% | ||
| PM (TTM) | 29.84% | ||
| GM | 60.69% | ||
| FCFM | 33.99% |
ROA(3y)26.51%
ROA(5y)23.13%
ROE(3y)39.59%
ROE(5y)36.39%
ROIC(3y)32.46%
ROIC(5y)33.96%
ROICexc(3y)37.5%
ROICexc(5y)37.01%
ROICexgc(3y)37.5%
ROICexgc(5y)37.01%
ROCE(3y)43.29%
ROCE(5y)45.29%
ROICexgc growth 3Y-7.82%
ROICexgc growth 5Y43.82%
ROICexc growth 3Y-7.82%
ROICexc growth 5Y43.82%
OM growth 3Y-2.15%
OM growth 5Y14.92%
PM growth 3Y10.62%
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y1.06%
F-Score6
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.09 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 140.25% | ||
| Cap/Sales | 17.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 94.07% | ||
| Profit Quality | 113.94% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 6.34 |
F-Score6
WACC8.03%
ROIC/WACC3.67
Cap/Depr(3y)180.21%
Cap/Depr(5y)207.89%
Cap/Sales(3y)19.72%
Cap/Sales(5y)21.17%
Profit Quality(3y)100.55%
Profit Quality(5y)107.06%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.15%
EPS 3Y10.83%
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.07%
Revenue growth 3Y-0.99%
Revenue growth 5Y38.14%
Sales Q2Q%-18.71%
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A
EBIT growth 1Y-11.49%
EBIT growth 3Y-3.12%
EBIT growth 5Y58.75%
EBIT Next Year28.61%
EBIT Next 3Y-3.62%
EBIT Next 5YN/A
FCF growth 1Y29.21%
FCF growth 3Y5.96%
FCF growth 5Y32.87%
OCF growth 1Y3.47%
OCF growth 3Y2.22%
OCF growth 5Y38.68%
HEMISPHERE ENERGY CORP / HME.CA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?
ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.
What is the valuation status for HME stock?
ChartMill assigns a valuation rating of 7 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.
What is the profitability of HME stock?
HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.
Can you provide the financial health for HME stock?
The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 8 / 10.
What is the earnings growth outlook for HEMISPHERE ENERGY CORP?
The Earnings per Share (EPS) of HEMISPHERE ENERGY CORP (HME.CA) is expected to decline by -8.04% in the next year.